Cargando…
A 3′UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1
BACKGROUND: The Polo-like Kinase 1 (PLK1) protein regulates cell cycle progression and is overexpressed in many malignant tissues. Overexpression is associated with poor prognosis in several cancer entities, whereby expression of PLK1 shows high inter-individual variability. Although PLK1 is extensi...
Autores principales: | Akdeli, Neval, Riemann, Kathrin, Westphal, Jana, Hess, Jochen, Siffert, Winfried, Bachmann, Hagen S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020576/ https://www.ncbi.nlm.nih.gov/pubmed/24767679 http://dx.doi.org/10.1186/1476-4598-13-87 |
Ejemplares similares
-
The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines
por: Klenke, Stefanie, et al.
Publicado: (2019) -
The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
por: de Cárcer, Guillermo
Publicado: (2019) -
Oncogenic potential of BEX4 is conferred by Polo-like kinase 1-mediated phosphorylation
por: Lee, Jin-Kwan, et al.
Publicado: (2018) -
Association of a Common Oxytocin Receptor Gene Polymorphism with Self-Reported ‘Empathic Concern’ in a Large Population of Healthy Volunteers
por: Huetter, Franz Korbinian, et al.
Publicado: (2016) -
Polo-like kinase in trypanosomes: an odd member out of the Polo family
por: Kurasawa, Yasuhiro, et al.
Publicado: (2020)